Chimerix Appoints Linda M. Richardson as Chief Commercial Officer DURHAM, N.C., Dec. 18, 2013 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the...
Audax Health Names David Ko President and Chief Operating Officer WASHINGTON, D.C. (DECEMBER 19, 2013) — Audax Health, a digital health development company that empowers consumers to lead healthier lives, today announced that board member David Ko will assume the role...
European Medicines Agency Accepts Marketing Authorization Application for Dalbavancin CHICAGO, Dec. 23, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced that the European Medicines Agency (EMA) has accepted for review a Marketing...
Recent Comments